TrialBlood advances2020

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.

Stephanie C Gergoudis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.